Shareholders Equity (Quarterly) Chart

Historical Shareholders Equity (Quarterly) Data

View and export this data back to 2009. Upgrade now.
Date Value
December 31, 2023 218.78M
September 30, 2023 209.94M
June 30, 2023 200.37M
March 31, 2023 199.34M
December 31, 2022 204.64M
September 30, 2022 200.25M
June 30, 2022 199.67M
March 31, 2022 194.02M
December 31, 2021 192.92M
September 30, 2021 193.53M
June 30, 2021 198.16M
March 31, 2021 186.03M
December 31, 2020 183.44M
September 30, 2020 159.97M
June 30, 2020 143.47M
March 31, 2020 127.52M
December 31, 2019 117.39M
September 30, 2019 98.99M
June 30, 2019 88.11M
March 31, 2019 77.56M
December 31, 2018 70.64M
September 30, 2018 55.98M
June 30, 2018 47.02M
March 31, 2018 38.97M
December 31, 2017 19.33M
Date Value
September 30, 2017 7.294M
June 30, 2017 7.738M
March 31, 2017 30.93M
December 31, 2016 28.89M
September 30, 2016 16.81M
June 30, 2016 20.20M
March 31, 2016 23.84M
December 31, 2015 26.06M
September 30, 2015 28.78M
June 30, 2015 31.28M
March 31, 2015 31.70M
December 31, 2014 36.29M
September 30, 2014 20.15M
June 30, 2014 16.63M
March 31, 2014 9.780M
December 31, 2013 6.918M
September 30, 2013 -2.150M
June 30, 2013 -0.778M
March 31, 2013 -7.727M
December 31, 2012 -10.12M
September 30, 2012 -14.27M
March 31, 2012 -4.742M
December 31, 2011 -1.540M
September 30, 2011 2.995M
June 30, 2011 5.914M

Shareholders' Equity Definition

Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.

Read full definition.

Shareholders Equity (Quarterly) Range, Past 5 Years

88.11M
Minimum
Jun 2019
218.78M
Maximum
Dec 2023
174.55M
Average
193.53M
Median
Sep 2021

Shareholders Equity (Quarterly) Benchmarks

uniQure NV 207.67M
ProQR Therapeutics NV 45.75M
Merus NV 356.34M
argenx SE 4.098B
Pharvaris NV 424.53M

Shareholders Equity (Quarterly) Related Metrics